Ace Report Cover
Oral alendronate cannot yet be recommended for children with OI
Reprints
Cite This
Reprints
Cite This
AceReport Image
Pediatric Orthopaedics
Oral alendronate cannot yet be recommended for children with OI
Verified
This report has been verified by one or more authors of the original publication.
J Clin Endocrinol Metab. 2011 Feb;96(2):355-64

139 children and adolescents with moderate to severe osteogenesis imperfecta (OI) were randomized to evaluate the safety and efficacy of oral alendronate (ALN). The trial primarily focused on the assessment of lumbar spine bone mineral density (LS BMD) alongside several secondary critera/data: clinical, radiological, biochemical, and multiple bone-related measurements and fracture details. Results demonstrated that ALN, compared to a placebo, effectively increased LS areal BMD z-scores, was adequately tolerated, and efficiently inhibited the activity of bone absorption. However, limited effect of ALN was observed in clinical parameters.

Unlock the full article

Get unlimited access to OrthoEvidence with a free trial
Start Trial

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or continue reading this full article
Register Now
AskOE
Search
Close Search Window
Welcome Back!
Forgot Password?
Create an Account

Account will be affiliated with


OR
Forgot Password?

OR
Check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see the email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. Oral alendronate cannot yet be recommended for children with OI. ACE Report. 2014;4(7):89. Available from: https://myorthoevidence.com/AceReport/Report/oral-alendronate-cannot-yet-be-recommended-for-children-with-oi

Copy Citation
Share this Ace Report